Buscar
Congreso SOLACI

Búsqueda de: aortic stenosis

Si no está conforme con los resultados, inténtelo de nuevamente.
Structural heart disease

TAVR in Bicuspid Patients: Are Outcomes the Same in Men and Women?

Bicuspid aortic valve stenosis (BAV) has not yet been analyzed in large, randomized studies, and TAVR in...
solaci -
Ir
Structural heart disease

Non-Cardiac Surgery After TAVR Is Safe

There are increasingly more patients who have undergone transcatheter aortic valve replacement (TAVR) and require a non-cardiac...
solaci -
Ir
Structural heart disease

The Best of the SOLACI-SOCIME 2022 Main Arena: Structural—Selected Topics of TAVR

On the last session from day 1 of SOLACI-SOCIME 2022 on structural pathology, Dr. Raj Makkar, an...
solaci -
Ir
Structural heart disease

TAVR, More Information Supports Its Use

TAVR has been reported beneficial in the treatment of high and intermediate risk patients but, initially, randomized...
solaci -
Ir
Structural heart disease

New-Generation ACURATE Neo2

Transcatheter aortic valve replacement (TAVR) is a therapeutical option for patients with symptomatic severe aortic stenosis. Current...
solaci -
Ir
Structural heart disease

EuroPCR 2022 | Should Revascularization Be Performed Before TAVR in Patients with Stable Coronary Disease?

Currently, the American and European guidelines recommend coronary angioplasty in patients with severe aortic stenosis with lesions...
solaci -
Ir
Institutional News

SOLACI Present at the Main Interventional Cardiology Meetings in the World

Once more, the Latin American Society of Interventional Cardiology (SOLACI) will attend two of the most important...
solaci -
Ir
Antiplatelet

ACC 2022 | ADAPT-TAVR: Endoxaban Is Not Superior to DAPT After TAVR

DAPT-TAVR is a randomized trial that tested endoxaban in patients with no indication for anticoagulation who underwent...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

solaci - 0
Hypertension treatment has evolved considerably over time. However, managing adverse events driven by medication is still challenging, as is low patient adherence, be it...

Myocardial Damage in MAC

solaci - 0
Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in women and patients with renal insufficiency. This...

Initial Complete Revascularization vs. Staged Revascularization in Patients with STEMI and Multivessel Disease

solaci - 0
In patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (primary PCI), multivessel disease is observed in up to 40%...

Noticias Institucionales

National and Internacional Live Cases at the Next SOLACI-CACI 2024

solaci - 0
Discover all the live national and international cases at the upcoming SOLACI-CACI 2024 Congress. Scientific program Register now con descuentos   Live International Transmission Tribute to Alain Cribier...

Discover the international guests of the SOLACI-CACI 2024 Congress

solaci - 0
We are getting closer to the largest gathering of interventional cardiologists in Latin America. Discover the prestigious guests from Europe, Asia, and the United...

New Issue of SOLACI-LATAM Peripheral Registry in the European Medical Journal

solaci - 0
We are proud to announce that the Latin American Society of Interventional Cardiology is sharing their latest issue of SOLACI-LATAM Peripheral Registry in the...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad